The immune response to the RT181-189 Epitope in HIV-1-Infected patients is associated with viral sequence polymorphism flanking the epitope

Journal of Clinical Immunology

Volumn 31, Issue 4, 2011, Pages 681-689

  Pacheco, Yovana ^a   Allavena, Clotilde ^a,b   Guilloux, Yannick ^a,c   Mueller Schmucker, Sandra M ^d   Hueckelhoven, Angela G ^d   André Garnier, Elisabeth ^a,e   Cleon, Fraņois ^a   Ferré, Virginie ^a,e   Rodallec, Audrey ^a,e   Billaud, Eric ^b   Harrer, Thomas ^d   Raffi, Fraņois ^b   McIlroy, Dorian ^a,f  

^a UNIVERSITÉ DE NANTES   (France)

^b Service d'Infectiologie   (France)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e HÔTEL DIEU   (France)

^f EA4271 Facultés de Médecine et de Pharmacie ^*  (France)

Author keywords

Antiviral drug resistance; Cytotoxic T lymphocytes; HIV 1 reverse transcriptase; T cell epitope

Indexed keywords

ANTIRETROVIRUS AGENT; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; LAMIVUDINE; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DNA FLANKING REGION; DNA POLYMORPHISM; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIROLOGY; VIRUS GENOME;

ADULT; AGED; ANTI-HIV AGENTS; CELLS, CULTURED; DRUG RESISTANCE, VIRAL; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPES, T-LYMPHOCYTE; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HLA-A2 ANTIGEN; HUMANS; INTERFERON-GAMMA; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 80555155600     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9520-z     Document Type: Article

References (29)

1. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650-5. (Pubitemid 24183063)
2. Jones NA, Wei X, Flower DR, Wong M, Michor F, Saag MS, et al. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med. 2004;200:1243-56. (Pubitemid 39552566)
3. Edwards BH, Bansal A, Sabbaj S, Bakari J, Mulligan MJ, Goepfert PA. Magnitude of functional CD8+ T-cell responses to the Gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol.2002;76:2298-305. (Pubitemid 34150698)
4. Zuñiga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, Hernandez A, et al. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol. 2006;80:3122-5. (Pubitemid 43346412)
5. Geldmacher C, Currier JR, Herrmann E, Haule A, Kuta E, McCutchan F, et al. Cd8 t-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J Virol. 2007;81:2440-8.
6. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, et al. Cd8+ t-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007;13:46-53. (Pubitemid 46067385)
7. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science. 2002;296:1439-43. (Pubitemid 34553083)
8. Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, et al. HLA-associated immune escape pathways in HIV-1 subtype b Gag, Pol and Nef proteins. PLoS ONE. 2009;4:e6687.
9. Kalams SA, Goulder PJ, Shea AK, Jones NG, Trocha AK, Ogg GS, et al. Levels of human immunodeficiency virus type 1-specific cytotoxic t-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J Virol. 1999;73:6721-8. (Pubitemid 29327855)
10. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 1998;279:2103-6. (Pubitemid 28196353)
11. Ogg GS, Jin X, Bonhoeffer S, Moss P, Nowak MA, Monard S, et al. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol. 1999;73:797-800. (Pubitemid 28565430)
12. Rehr M, Cahenzli J, Haas A, Price DA, Gostick E, Huber M, et al. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J Virol. 2008;82:3391-404. (Pubitemid 351429916)
13. Palmer S, Maldarelli F, Wiegand A, Bernstein B, Hanna GJ, Brun SC, et al. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci USA.2008;105:3879-84. (Pubitemid 351723493)
14. Samri A, Haas G, Duntze J, Bouley JM, Calvez V, Katlama C, et al. Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic t cells. J Virol. 2000;74:9306-12.
15. Mason RD, Bowmer MI, Howley CM, Gallant M, Myers JCE, Grant MD. Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes. J Immunol. 2004;172:7212-9.
16. Karlsson AC, Deeks SG, Barbour JD, Heiken BD, Younger SR, Hoh R, et al. Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene. J Virol. 2003;77:6743-52. (Pubitemid 36666868)
17. Schmitt M, Harrer E, Goldwich A, Bäuerle M, Graedner I, Kalden JR, et al. Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes. AIDS. 2000;14:653-8. (Pubitemid 30229344)
18. Stratov I, Dale CJ, Chea S, McCluskey J, Kent SJ. Induction of T-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1. J Virol. 2005;79:7728-37. (Pubitemid 40756806)
19. Mueller YM, Bojczuk PM, Halstead ES, Kim AHJ, Witek J, Altman JD, et al. IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood. 2003;101:1024-9. (Pubitemid 36139375)
20. Karlsson AC, Chapman JM, Heiken BD, Hoh R, Kallas EG, Martin JN, et al. Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to Pol. J Virol. 2007;81:11543-8. (Pubitemid 47536126)
21. Gu Z, Gao Q, Li X, Parniak MA, Wainberg MA. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine. J Virol. 1992;66:7128-35.
22. Harrer E, Harrer T, Barbosa P, Feinberg M, Johnson RP, Buchbinder S, et al. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLAa2- restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J Infect Dis. 1996;173:476-9.
23. Dalod M, Harzic M, Pellegrin I, Dumon B, Hoen B, Sereni D, et al. Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy. J Infect Dis. 1998;178:61-9. (Pubitemid 28328077)
24. Karlsson AC, Iversen AKN, Chapman JM, de Oliviera T, Spotts G, McMichael AJ, et al. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PLoS ONE. 2007;2:e225.
25. Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T. Recognition patterns of HLA-a2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals. Viral Immunol. 2005;18:627-36. (Pubitemid 43038527)
26. Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, Brander C, et al. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med. 2004;199:905-15. (Pubitemid 38481082)
27. Milicic A, Price DA, Zimbwa P, Booth BL, Brown HL, Easterbrook PJ, et al. CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef. J Immunol.2005;175:4618-26.
28. Le Gall S, Stamegna P, Walker BD. Portable flanking sequences modulate CTL epitope processing. J Clin Invest. 2007;117:3563-75.
29. Tenzer S, Wee E, Burgevin A, Stewart-Jones G, Friis L, Lamberth K, et al. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol. 2009;10:636-46.